Historical and Novel Glycobiological Biomarkers of Cancer and Disease Progression Novel Glycobiological Mechanisms Driving Cancer Progression Novel Methods for Discovering Glycobiological Biomarkers of Cancer.

Seller Inventory # 737169750

Contact seller

Report this item

Bibliographic Details

Title: Novel Methods and Pathways in Cancer Glycobiology Research
Publisher: Elsevier Science
Publication Date: 2023
Language: English
ISBN 10: 0323991777
ISBN 13: 9780323991773
Binding: Hardcover
Condition: New

About this title

Synopsis

Cancer glycobiology is a blazing hot area of cancer research with aberrant post-translational glycosylations on lipids and proteins considered critical for cancer development and metastasis. The NIH/NCI Alliance of Glycobiologists for Cancer Research is a consortium of (10) tumor glycobiology laboratories funded to investigate how cancer-associated glycans (CAG) impact the development and metastasis of cancer. The hope of this momentous effort is to discover CAGs for use as novel biomarkers to detect early-stage cancer or its aggressive behavior or, alternatively, as novel molecular targets with the promise of a curative approach to cancer therapy. The mission of the ‘Alliance’ is to study structure and function of CAGs in cancer development and to provide clinically useful biomarkers for detecting cancer early or the potential of metastasis. This charge has stimulated extensive collaborations across US and International institutions to accelerate discovery of glycan-based biomarkers to the forefront of NCI's efforts to diagnose early-stage cancer and provide curative anti-cancer therapies.

The main goals of these research efforts are:
1. To identify and study how cancer-associated glycans functionally impact cancer growth and metastasis
2. To identify cancer-associated glycans that can serve as biomarkers for the detection or progression of cancer
3. To develop cancer-associated glycans as novel therapeutic targets for the treatment and cure of cancer

This volume consists of (9) chapters, one from each funded laboratory, that reviews new methods and mechanisms highlighting glycoconjugates and their roles as cancer biomarkers and/or anti-cancer therapeutic targets.

Historical and Novel Glycobiological Biomarkers of Cancer and Disease Progression
Novel Glycobiological Mechanisms Driving Cancer Progression
Novel Methods for Discovering Glycobiological Biomarkers of Cancer

About the Authors

Over the last 26 years, Dr. Dimitroff has established himself as leader in field of glycobiology and is highly motivated to translate his glycobiological findings to help cure diseases and improve the health of humans. His research focuses on understanding how sugars or ‘glycans’ regulate immune and cancer cell functions with the goal of developing new approaches to boost the immune system to fight diseases and to treat cancer progression. These efforts have led to a laboratory that operates one of the preeminent translational glycobiology programs in the US.

Dr. Dimitroff spent his initial years as an independent PI at Brigham and Women’s Hospital (BWH)/Harvard Medical School (HMS) transitioning from Instructor to Associate Professor of Dermatology in the Department of Dermatology. He was a Faculty Member in the Harvard Immunology Ph.D. Program and was the Associate Director for Laboratory Research in BWH Dermatology. In 2019, he then joined the Herbert Wertheim College of Medicine (HWCOM) at Florida International University (FIU) as the Executive Associate Dean for Research and Professor (with Tenure) of Translational Medicine. He now has concentrated his administrative duties focusing as the Founding Director of the Translational Glycobiology Institute at FIU (TGIF), wherein he oversees translational glycoscience research. The TGIF is a one-of-kind institute with translational glycoscience investigators seeking cures for diseases and providing research opportunities for trainees at all academic levels with a special focus on underrepresented minorities and women in science.

Dr. Dimitroff’s current translational glycobiology research is subdivided into (2) Programs: a Solid Cancer Research Program and an Immune Research Program. In the Solid Cancer Research Program, his research explores the glycome of metastatic melanomas and ascertains how the glycome drives melanoma metastasis and whether these glycobiological features can be used as biomarkers to predict melanoma metastasis. In the Immune Research Program, his research investigates how human B cell glycans control B cell fate and function. These investigations have unveiled new molecular insights on the regulation of a humoral immune response and vaccinations, and the treatment of B cell malignancies.

Dr. Karen Abbott has been a leader in the field of glycoproteomics and biomarker discovery for over 14 years. Dr. Abbott received her PhD in Biochemistry at The University of Georgia in 2004. She was awarded an American Cancer Society Postdoctoral Fellowship in 2005 where she developed lectin capture methods for the analysis of glycoproteins from human tissues and plasma using mass spectrometry methods. She has been funded for ovarian cancer research by since 2010. She is currently funded by an Alliance of Glycobiologists NCI grant to understand how complex carbohydrates contribute to the development and progression of ovarian cancer. She is also currently funded by the NCI Innovative Molecular Analysis Technologies grant that supports the development of novel and transformative technologies to develop new therapeutics and diagnostics for cancer. Dr. Abbott joined the Herbert Wertheim College of Medicine (HWCOM) at Florida International University in 2020 as Associate Director for the Translational Glycobiology Institute. Her research is currently focused in three main areas: translational therapeutic development for ovarian cancer, studies on the role of Notch glycosylation in ovarian cancer progression, and technology development for the study of glycosylphosphatidylinositol anchored proteins.

"About this title" may belong to another edition of this title.

Store Description

Online Handel nur mit Neub�chern

Visit Seller's Storefront

Seller's business information

Moluna GmbH
Engberdingdamm 27, Greven, 48268, Germany

Sale & Shipping Terms

Terms of Sale

Instructions for revocation/
Standard Business Terms and customer information/ data protection declaration

Revocation right for consumers
(A ?consumer? is any natural person who concludes a legal transaction which, to an overwhelming extent, cannot be attributed to either his commercial or independent professional activities.)

Instructions for revocation

Revocation right
You have the right to revoke this contract within one month without specifying any reasons.
The revocation period is one month...

More Information

Shipping Terms

II. Kundeninformationen

Identit�t des Verk�ufers

Moluna GmbH
Engberdingdamm 27
48268 Greven
Deutschland
Telefon: 02571/5698933
E-Mail: abe@moluna.de

Wir sind nicht bereit und nicht verpflichtet, an Streitbeilegungsverfahren vor Verbraucherschlichtungsstellen teilzunehmen.

Informationen zum Zustandekommen des Vertrages

Die technischen Schritte zum Vertragsschluss, der Vertragsschluss selbst und die Korrekturm�glichkeiten erfolgen nach Ma�gabe der Regelungen "Zustandekommen des Vertrages" unserer Allgemeinen Gesch�ftsbedingungen (Teil I.).

Vertragssprache, Vertragstextspeicherung

3.1. Vertragssprache ist deutsch .

3.2. Der vollst�ndige Vertragstext wird von uns nicht gespeichert. Vor Absenden der Bestellung k�nnen die Vertragsdaten �ber die Druckfunktion des Browsers ausgedruckt oder elektronisch gesichert werden. Nach Zugang der Bestellung bei uns werden die Bestelldaten, die gesetzlich vorgeschriebenen Informationen bei Fernabsatzvertr�gen und die Allgemeinen Gesch�ftsbedingungen nochmals per E-Mail an Sie �bersandt.

Wesentliche Merkmale der Ware oder Dienstleistung

Die wesentlichen Merkmale der Ware und/oder Dienstleistung finden sich im jeweiligen Angebot.

Preise und Zahlungsmodalit�ten

5.1. Die in den jeweiligen Angeboten angef�hrten Preise sowie die Versandkosten stellen Gesamtpreise dar. Sie beinhalten alle Preisbestandteile einschlie�lich aller anfallenden Steuern.

5.2. Die anfallenden Versandkosten sind nicht im Kaufpreis enthalten. Sie sind �ber eine entsprechend bezeichnete Schaltfl�che auf unserer Internetpr�senz oder im jeweiligen Angebot aufrufbar, werden im Laufe des Bestellvorganges gesondert ausgewiesen und sind von Ihnen zus�tzlich zu tragen, soweit nicht die versandkostenfreie Lieferung zugesagt ist.

5.3. Die Ihnen zur Verf�gung stehenden Zahlungsarten sind unter einer entsprechend bezeichneten Schaltfl�che auf unserer Internetpr�senz oder im jeweiligen Angebot ausgewiesen.

5.4. Soweit bei den einzelnen Zahlungsarten nicht anders angegeben, sind die Zahlungsanspr�che aus dem geschlossenen Vertrag sofort zur Zahlung f�llig.

Lieferbedingungen

6.1. Die Lieferbedingungen, der Liefertermin sowie gegebenenfalls bestehende Lieferbeschr�nkungen finden sich unter einer entsprechend bezeichneten Schaltfl�che auf unserer Internetpr�senz oder im jeweiligen Angebot.

Soweit im jeweiligen Angebot oder unter der entsprechend bezeichneten Schaltfl�che keine andere Frist angegeben ist, erfolgt die Lieferung der Ware innerhalb von 3-5 Tagen nach Vertragsschluss (bei vereinbarter Vorauszahlung jedoch erst nach dem Zeitpunkt Ihrer Zahlungsanweisung).

6.2. Soweit Sie Verbraucher sind ist gesetzlich geregelt, dass die Gefahr des zuf�lligen Untergangs und der zuf�lligen Verschlechterung der verkauften Sache w�hrend der Versendung erst mit der �bergabe der Ware an Sie �bergeht, unabh�ngig davon, ob die Versendung versichert oder unversichert erfolgt. Dies gilt nicht, wenn Sie eigenst�ndig ein nicht vom Unternehmer benanntes Transportunternehmen oder eine sonst zur Ausf�hrung der Versendung bestimmte Person beauftragt haben.

Sind Sie Unternehmer, erfolgt die Lieferung und Versendung auf Ihre Gefahr.

Gesetzliches M�ngelhaftungsrecht

Die M�ngelhaftung richtet sich nach der Regelung "Gew�hrleistung" in unseren Allgemeinen Gesch�ftsbedingungen (Teil I).

letzte Aktualisierung: 23.10.2019

Shipping rates from Germany to U.S.A.

Shipping rates from Germany to U.S.A.
Order quantity	26 to 60 business days	26 to 60 business days
First item	US$ 56.68	US$ 56.68

Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.